CHANTEL GREEN: Open Payments
NPI 1457075889 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,114 in 137 payments from 35 companies in 2025. Trend: 2023 $2,738 · 2024 $2,898 · 2025 $3,114
Food & beverage: $2,934Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $289 |
| ABBVIE INC. | 8 | $268 |
| Novartis Pharmaceuticals Corporation | 11 | $259 |
| AstraZeneca Pharmaceuticals LP | 6 | $233 |
| E.R. Squibb & Sons, L.L.C. | 18 | $220 |
| Daiichi Sankyo Inc. | 10 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $171 |
| PFIZER INC. | 7 | $164 |
| Merck Sharp & Dohme LLC | 7 | $137 |
| Incyte Corporation | 5 | $101 |
Products named: ENHERTU, VENCLEXTA, DARZALEX, KEYTRUDA, OPDUALAG, OPDIVO, KISQALI, OJJAARA.
Industry payments across MO — which companies pay providers there.
